#Eu­ro­Bio23: The down­turn, tak­ing risks and the ‘biotech mafia’

What’s in store for biotech and phar­ma in Eu­rope? If one thing was clear from day one of End­points News’ Eu­ro­Bio sum­mit, it ap­pears to be that the an­swer is in­ter­twined with the rest of the world.

The re­gion, af­ter all, is home to phar­ma gi­ants like As­traZeneca, GSK, Roche, No­vo Nordisk and No­var­tis, with ris­ing stars like Den­mark’s Gen­mab and the Nether­lands’ ar­genx in­creas­ing­ly tak­ing the spot­light on the glob­al stage.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER